Toolkit/SHERLOCK

SHERLOCK

Assay Method·Research·Since 2025

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Emerging CRISPR-based diagnostics (e.g., SHERLOCK and DETECTR)

Usefulness & Problems

Why this is useful

SHERLOCK is named as an emerging CRISPR-based diagnostic in the review abstract. It is discussed in the context of enhancing safety, stratification, and monitoring of CRISPR therapeutics.; CRISPR-based diagnostics; safety enhancement; patient stratification; monitoring of CRISPR therapeutics

Source:

SHERLOCK is named as an emerging CRISPR-based diagnostic in the review abstract. It is discussed in the context of enhancing safety, stratification, and monitoring of CRISPR therapeutics.

Source:

CRISPR-based diagnostics

Source:

safety enhancement

Source:

patient stratification

Source:

monitoring of CRISPR therapeutics

Problem solved

The abstract positions SHERLOCK as part of the diagnostic layer supporting safer and better-monitored CRISPR therapeutic development.; supports diagnostic monitoring and stratification around CRISPR therapeutics

Source:

The abstract positions SHERLOCK as part of the diagnostic layer supporting safer and better-monitored CRISPR therapeutic development.

Source:

supports diagnostic monitoring and stratification around CRISPR therapeutics

Problem links

Limited Diagnostic Tools Optimized for Low-Resource Settings

Gap mapView gap

SHERLOCK is explicitly identified as an emerging CRISPR-based diagnostic platform, so it is mechanistically relevant to rapid molecular detection of pathogens. It could plausibly contribute to more informative diagnostics than simple single-analyte tests.

supports diagnostic monitoring and stratification around CRISPR therapeutics

Literature

The abstract positions SHERLOCK as part of the diagnostic layer supporting safer and better-monitored CRISPR therapeutic development.

Source:

The abstract positions SHERLOCK as part of the diagnostic layer supporting safer and better-monitored CRISPR therapeutic development.

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete measurement method used to characterize an engineered system.

Mechanisms

No mechanism tags yet.

Target processes

diagnosticediting

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor

Operational role: sensor. Implementation mode: genetically encoded. Cofactor status: cofactor requirement unknown.

Independent follow-up evidence is still limited. Validation breadth across biological contexts is still narrow. Independent reuse still looks limited, so the evidence base may be fragile. No canonical validation observations are stored yet, so context-specific performance remains under-specified.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1diagnostic supportsupports2025Source 1needs review

CRISPR-based diagnostics such as SHERLOCK and DETECTR, together with AI-assisted sgRNA design and machine-learning off-target prediction, enhance the safety, stratification, and monitoring of CRISPR therapeutics.

Claim 2performance advantagesupports2025Source 1needs review

Base editing, prime editing, CRISPRi/a, and RNA-targeting Cas systems improve precision and reduce genomic damage, which is particularly advantageous in post-mitotic neurons.

Approval Evidence

1 source1 linked approval claimfirst-pass slug sherlock
Emerging CRISPR-based diagnostics (e.g., SHERLOCK and DETECTR)

Source:

diagnostic supportsupports

CRISPR-based diagnostics such as SHERLOCK and DETECTR, together with AI-assisted sgRNA design and machine-learning off-target prediction, enhance the safety, stratification, and monitoring of CRISPR therapeutics.

Source:

Comparisons

Source-backed strengths

explicitly cited as an emerging CRISPR-based diagnostic

Source:

explicitly cited as an emerging CRISPR-based diagnostic

Compared with DETECTR

SHERLOCK and DETECTR address a similar problem space because they share diagnostic, editing.

Shared frame: same top-level item type; shared target processes: diagnostic, editing

SHERLOCK and nanotechnology-enhanced biosensors address a similar problem space because they share diagnostic, editing.

Shared frame: same top-level item type; shared target processes: diagnostic, editing

SHERLOCK and spatial transcriptomics address a similar problem space because they share diagnostic, editing.

Shared frame: same top-level item type; shared target processes: diagnostic, editing

Relative tradeoffs: appears more independently replicated.

Ranked Citations

  1. 1.
    StructuralSource 1MED2025Claim 1Claim 2

    Seeded from load plan for claim c4. Extracted from this source document.